NCT01362881

Brief Summary

It is current practice for children who have surgery for early onset scoliosis (EOS) to be treated with insertion of extendable implants known as growth rod systems. This allows the growth potential of the child to be maximised during the period of growth. However, the child must undergo an average of 6 further surgeries to lengthen the rods every 6 months. Sometimes this may continue for several years. This requires repeated general anaesthesia and places the patient at risk of complications as well as on-going costs to the hospital with each admission and theatre episode. Magec is a magnetic growth rod from Ellipse technologies (distributed by SurgiC). The rod is inserted in exactly the same way as the conventional growth rod systems. The base implants i.e screws and hooks remain the preferred choice of the user. The only change is that a different rod is used. There are several advantages to this device. Firstly, after the initial insertion, further lengthenings, unlike current systems, do not need to be carried out in theatre under a general anaesthetic. In contrast, they can be done in an outpatients setting with a non-invasive technique. The rods are lengthened using an external magnetic device. The lengthenings are done in a controlled manner using an age related growth guide. Thirdly, the change from a theatre based intervention to an outpatient procedure will have cost-savings. The investigators also believe that there will be psychosocial benefits to the child and family by the avoiding the stress associated with repeated surgery at such a young age. In terms of risk assessment the device does not place the child at any more risk than would be expected from inserting any of the existing systems. In the event of failure of the rods the worst outcome is a revision to conventional rods.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
14

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jan 2012

Longer than P75 for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 27, 2011

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 30, 2011

Completed
7 months until next milestone

Study Start

First participant enrolled

January 1, 2012

Completed
4.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2016

Completed
1.6 years until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2017

Completed
Last Updated

September 1, 2017

Status Verified

June 1, 2017

Enrollment Period

4.1 years

First QC Date

May 27, 2011

Last Update Submit

August 31, 2017

Conditions

Keywords

EarlyOnsetScoliosis

Outcome Measures

Primary Outcomes (1)

  • To Assess the Safety and effectiveness of a Magnetic Growth Rod

    2 Years From Final Recruitment Date

Eligibility Criteria

Age2 Years - 10 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Study population will be recruited from secondary care

You may qualify if:

  • Patient aged 2 - 10 years (male/female) with EOS and growth potential
  • Patient who surgeon feels would benefit from the implantation of a growth rod
  • Patient must be of appropriate size and age for use of the device
  • Patient's guardian is willing and able to give informed consent for participation in the study
  • Patient (and guardian) is willing and able to return for all follow-up visits and study related procedures
  • The patient's guardian is willing to allow his or her General Practitioner and consultant, if appropriate, to be notified of participation in the study

You may not qualify if:

  • The participant may not enter the study if ANY of the following apply:
  • Conversion patients with prior construct problems
  • Previous diagnosis of post-operative spinal infection or wound complication
  • Conversion patients with more than 3 previous distractions, or more than 2 years since initial surgery
  • Patients with prior failure of other devices
  • Any other significant disease or disorder which, in the opinion of the Investigator, may either put the participants at risk because of participation in the study, or may influence the result of the study, or the participant's ability to participate in the study
  • Participants who have participated in another research study involving an investigational product in the past 12 weeks

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Leeds Teaching Hospitals

Leeds, United Kingdom

Location

Oxford University NHS Trust

Oxford, United Kingdom

Location

Related Links

MeSH Terms

Conditions

Scoliosis

Condition Hierarchy (Ancestors)

Spinal CurvaturesSpinal DiseasesBone DiseasesMusculoskeletal Diseases

Study Officials

  • Colin Nnadi

    Consultant Surgeon

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 27, 2011

First Posted

May 30, 2011

Study Start

January 1, 2012

Primary Completion

February 1, 2016

Study Completion

August 31, 2017

Last Updated

September 1, 2017

Record last verified: 2017-06

Locations